Low dose naltrexone gives new hope to individuals looking for help with their Lyme disease symptoms. Learn how low dose naltrexone may help you cope with the symptoms that plague you.
Lyme disease is a bacterial infection transmitted through tick bites. It can cause a wide range of symptoms, including pain, inflammation, and a suppressed immune system. The bacterium that causes Lyme disease can wreak havoc on the human immune system. It disguises itself inside the body, so that your immune system does not even know that it needs to produce antibodies to fight off the bacteria. Then, when it finally unleashes itself on your cells, it tricks your immune system into attacking your own tissues with a massive inflammatory response that causes damage to you without destroying the Lyme bacteria.
This is why Lyme disease is so dangerous. The bacteria itself is not destroying your joints, nervous system, and other systems. It is the toxic levels of compounds released by your own immune cells. LDN helps to cool down that inflammation and re-regulate your immune response. This makes it easier to treat the bacteria and reduce the damage to your body systems.
Low dose naltrexone (LDN) is not a cure for Lyme disease and does not replace your current treatment. That being said, Lyme disease can really leave your body weakened and exhausted. That is where LDN comes in. It can be used as a part of your treatment regimen in order to boost your immune system and reduce the pain and inflammation caused by advanced Lyme disease.
Although other pain relievers and anti-inflammatories are available, studies have shown that LDN can be helpful for relieving pain and inflammation. And not only that, it also improves the immune system functioning of Lyme disease sufferers.
Over-the-counter pain relievers are readily available, but they are not a good long-term solution. Many of them can cause unwanted side effects, and even serious health issues down the road, such as liver problems and stomach ulcers. LDN, on the other hand, has few side effects, such as mild headaches, sleep disturbances, or vivid dreams, and these generally go away during the course of treatment. Also, LDN is not expensive or habit forming.
Share this valuable information with anyone you know who has been diagnosed with Lyme disease. It could make all the difference in their health and quality of life.
Living with Lyme disease is difficult, and treatment can take years to complete. But LDN offers a way to protect your joints, nervous system, and brain from the harmful effects of this illness. Reach out to our compounding pharmacy in Leesburg today to learn more about low dose naltrexone for your Lyme disease symptoms.
Bihari B (2013) Bernard Bihari, MD: low-dose naltrexone for normalizing immune system function. Altern Ther Health Med 19(2):56–65
Chopra, P, Cooper, MS. Treatment of Complex Regional Pain Syndrome (CRPS) Using Low Dose Naltrexone (LDN). Journal of Neuroimmune Pharmacology J Neuroimmune Pharmacol. 2013:470–476.
Donahue, RN, Mclaughlin, PJ, Zagon, IS. The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice. Gynecologic Oncology.:382– 388.
Meng, J, Meng, Y, Plotnikoff, NP, Youkilis, G, Griffin, N, Shan, F. Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs). International Immunopharmacology.:1084–1089.
Rahn, KA, Mclaughlin, PJ, Zagon, IS. Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis. Brain Research.:243–253.
Brain Behav Evol. 2010;76(2):154-62. doi: 10.1159/000320968. Epub 2010 Nov 15. Extensive changes in the expression of the opioid genes between humans and chimpanzees. Cruz-Gordillo P1
PLoS Biol. 2005 Dec; 3(12): e387. Ancient and Recent Positive Selection Transformed Opioid cis-Regulation in Humans, Matthew V
Younger, J, Noor, N, Mccue, R, Mackey, S. Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis & Rheumatism. 2013:529– 538.
Younger, J, Parkitny, L, Mclain, D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol Clinical Rheumatology. 2014:451–459.